$PRSC (Providence Service Corp.)

$PRSC {{ '2016-07-06T18:37:24+0000' | timeago}} • Announcement

Holding company providing critical healthcare and workforce developments services $PRSC said that the company appointed Todd Carter, David Coulter and Frank Wright to the company's Board of Directors. The company also said that the addition of these three people to the Board of Directors increases the number of directors to eight.

$MMS {{ '2018-01-16T21:43:43+0000' | timeago}} • Announcement

$MMS announced that Richard A. Montoni will retire from his role as CEO effective April 1, 2018. The Board of Directors has selected President Bruce L. Caswell to succeed Mr. Montoni as CEO.

$MMS {{ '2018-01-11T13:24:10+0000' | timeago}} • Announcement

$MMS has declared a quarterly cash dividend of $0.045 per share on its common stock. The dividend is payable on February 28, 2018, to shareholders of record on February 15, 2018.

$MD {{ '2018-01-10T15:20:12+0000' | timeago}} • Announcement

$MD announced the acquisition of Tri-Valley Neonatal Medical Group, Inc., a private neonatology physician practice based in California. This was a cash transaction and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.

$HUM {{ '2017-12-19T15:27:46+0000' | timeago}} • Announcement

$HUM signed a definitive agreement to acquire a 40% minority interest in the Kindred at Home Division of $KND for an estimated cash consideration of approximately $800MM. Humana does not anticipate a material impact to earnings in 2017 from this pending transaction.

$KND {{ '2017-12-19T13:44:51+0000' | timeago}} • Announcement

$KND's BoD approved a definitive agreement whereby it will be acquired by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe and $HUM for about $4.1Bil in cash including the assumption or repayment of net debt. The transaction is expected to close during the summer of 2018.

$PMC {{ '2017-12-07T18:06:23+0000' | timeago}} • Announcement

$PMC announced the completion of the acquisition of PharMerica by a newly formed company controlled by KKR with an affiliate of $WBA as a minority investor.

$CVS {{ '2017-12-04T21:29:13+0000' | timeago}} • Announcement

$CVS has agreed to acquire $AET for appox. $207 per share or approx. $69Bil. Including the assumption of $AET debt, the total value of the deal is $77Bil. The transaction is expected to close in the second half of 2018.

$LHCG {{ '2017-12-04T19:56:36+0000' | timeago}} • Announcement

$LHCG and Erlanger Health System have finalized a new JV to enhance home health and community-based services in Chattanooga and southeast Tennessee. The JV includes a Chattanooga facility, which will operate as Erlanger ContinuCare Home Health. $LHCG expects annualized revenue from this JV of approx. $7MM and no material effect to 2017 diluted EPS.

$LHCG {{ '2017-11-16T14:14:41+0000' | timeago}} • Announcement

$LHCG-$AFAM merger will create a nationwide provider of in-home healthcare services. The combined company will have 781 locations in 36 states with more than 31,000 employees and revenue of $1.8Bil and adjusted EBITDA of approx. $145MM for the trailing 12-month period ended Sept. 30, 2017.

$LHCG {{ '2017-11-16T14:13:01+0000' | timeago}} • Announcement

$LHCG and $AFAM have agreed to combine in an all-stock merger of equals transaction. Almost Family shareholders will receive 0.9150 shares of LHC Group for each existing Almost Family share. Upon closing of the transaction, LHC Group shareholders will own 58.5% and Almost Family shareholders will own 41.5% of the combined company.

$EVHC {{ '2017-11-15T19:08:37+0000' | timeago}} • Infographic

$EVHC Envision Healthcare Holdings, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$CVS {{ '2017-11-08T12:39:44+0000' | timeago}} • Webcast

For 4Q17, $CVS expects a negative free cash flow, as the company plans to settle the CMS payable associated with the 2016 plan year. Based on this the company maintains its FY17 guidance and continues to expect to produce free cash of between $6-6.4Bil

$CVS {{ '2017-11-08T12:33:21+0000' | timeago}} • Webcast

$CVS entered into a five-year agreement with $ANTM during 3Q17. Based on this, $CVS will offer its services to support $ANTM's new pharmacy benefit management company called IngenioRx, effective January 2020. The services include claims processing and prescription fulfillment through mail order and specialty pharmacies.

$CVS {{ '2017-11-08T12:24:47+0000' | timeago}} • Webcast

During 3Q17, $CVS experienced a negative effect of the three major hurricanes that hit Southern U.S. and Puerto Rico. The hurricanes along with retail weakness is what contributed to lower earnings during the quarter. The storm triggered a financial impact of approx. $55MM, which are costs primarily to cover insurance deductibles.

$CVS {{ '2017-11-06T18:42:25+0000' | timeago}} • Announcement

$CVS to bring next-day delivery from CVS Pharmacy locations beginning in early 2018. The company plans to offer free same-day delivery within hours in selected markets. $CVS continues to expand its partnership with Instacart to offer personal shopping at 2,600 CVS Pharmacy stores across the country.

$CVS {{ '2017-11-06T18:20:05+0000' | timeago}} • Announcement

$CVS, that proposed to buy $AET, reported a 17% drop in its 3Q17 profit, mainly due to reimbursement pressure and $187MM of losses on pension settlements. Net income during the quarter fell to $1.28Bil, or $1.26 per share, from $1.54Bil, or $1.44 per share during 3Q16. Adj. EPS was $1.50, down 9%. Revenues rose 4% YoY to $46.2Bil.

$CVS {{ '2017-11-06T18:08:02+0000' | timeago}} • Announcement

$CVS has narrowed its guidance for FY17. The company currently estimates its GAAP EPS to be about $4.98-5.02 from $4.92-5.02 and adj. EPS to be about $5.87-5.91 from $5.83-5.93.

$CVS {{ '2017-11-06T17:57:44+0000' | timeago}} • Announcement

During 3Q17, $CVS's Pharmacy Services Segment reported 8.1% increase in its revenue to approx. $32.9Bil, driven by growth in the pharmacy network claim volume. Revenues in the Retail/LTC Segment decreased 2.7% to approx. $19.6Bil. The fall in revenue was mainly due to 3.2% decrease in same store sales.

$CVS {{ '2017-11-06T12:53:26+0000' | timeago}} • Infographic

$CVS CVS Health Corp. Earnings AlphaGraphic: Q3 2017 highlights

$WBA {{ '2017-10-25T14:13:26+0000' | timeago}} • Announcement

$WBA, the second largest pharmacy store chain in the US posted a 22% fall in profit to $802MM or $0.76 per share, hurt by a $300MM fee paid to $RAD post their failed merger attempt. Conversely, revenue rose 5.2% to $30.1Bil, driven by expansion of $WBA's mail service through its specialty pharma & mail services company AllianceRx Walgreens Prime.

Recent Transcripts

RAD (Rite Aid Corporation)
Wednesday, January 3 2018 - 10:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
Thursday, November 9 2017 - 2:00pm
AMED (Amedisys Inc.)
Wednesday, November 8 2017 - 4:00pm
PRSC (Providence Service Corp.)
Wednesday, November 8 2017 - 1:00pm
KND (Kindred Healthcare Inc.)
Tuesday, November 7 2017 - 2:00pm
LHCG (LHC Group, Inc.)
Monday, November 6 2017 - 4:00pm
CVS (CVS Health Corporation)
Monday, November 6 2017 - 1:30pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
USPH (US Physical Therapy Inc.)
Thursday, November 2 2017 - 2:30pm
BIOS (BioScrip, Inc.)
Thursday, November 2 2017 - 1:00pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
Wednesday, November 1 2017 - 2:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Wednesday, November 1 2017 - 12:30pm
CHE (Chemed Corp.)
Friday, October 27 2017 - 2:00pm
TVTY (Tivity Health, Inc.)
Thursday, October 26 2017 - 9:00pm
PETS (PetMed Express, Inc.)
Monday, October 23 2017 - 12:30pm
RAD (Rite Aid Corporation)
Thursday, September 28 2017 - 12:30pm
PTN (Palatin Technologies Inc.)
Monday, September 25 2017 - 3:00pm

AlphaGraphics you may like